With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia||Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD||'A' Award Grants||2012||New York|
|Dana-Farber/Children's Hospital Cancer Center Developmental Therapeutics Center of Excellence||Dana-Farber Cancer Institute / Steven DuBois, MD & Wendy London, PhD||Center of Excellence Grants||2012||Massachusetts|
|Discovery of New Targets and Pathways for T-ALL Therapy||Dana-Farber Cancer Institute / Thomas Look||Bridge Grants||2012||Massachusetts|
|Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening||Dana-Farber Cancer Institute / Stuart Orkin, MD||Innovation Grants||2012||Massachusetts|
|Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen||Dana-Farber Cancer Institute / David Pellman, MD||Innovation Grants||2012||Massachusetts|
|SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia||Dana-Farber Cancer Institute / Jennifer Wu||Young Investigator Grants||2012||Massachusetts|
|Selective inhibition of nuclear export as a novel therapeutic strategy in AML||Dana-Farber Cancer Institute / Julia Etchin||Young Investigator Grants||2012||Massachusetts|
|Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma||Dana-Farber Cancer Institute / Kimberly Stegmaier, MD||Bridge Grants||2012||Massachusetts|
|Mechanisms of PPM1D in Medulloblastoma Tumorigenesis and Invasion||Emory University / Robert Craig Castellino, MD||Bridge Grants||2012||Georgia|
|Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD||'A' Award Grants||2012||Washington|